Stock Is Skyrocketing This Week

benzinga.com/trading-ideas/movers/25/06/45932876/why-urogen-pharma-urgn-stock-is-skyrocketing-this-week

UroGen Pharma Ltd (NASDAQ:URGN) shares are surging this week following the U.S. Food and Drug Administration approval of ZUSDURI, a novel treatment for a specific type of bladder cancer.
What To Know: UroGen says this decision marks the first and only FDA-approved medication for adults…

This story appeared on benzinga.com, 2025-06-13 18:42:35.
The Entire Business World on a Single Page. Free to Use →